Ponvory
| Chemical Name | ponesimod |
| Dosage Form | Tablet (oral; 2 mg, 3 mg, 4 mg, 5 mg, 6 mg, 7 mg, 8 mg, 9 mg, 10 mg, 20 mg) |
| Drug Class | Sphingosine 1-phosphate receptor modulators |
| System | Multiple |
| Company | Janssen Pharmaceuticals |
| Approval Year | 2021 |
Indication
- Indicated for the treatment of relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.